These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27026197)

  • 41. Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer.
    von Forstner C; Egberts JH; Ammerpohl O; Niedzielska D; Buchert R; Mikecz P; Schumacher U; Peldschus K; Adam G; Pilarsky C; Grutzmann R; Kalthoff H; Henze E; Brenner W
    J Nucl Med; 2008 Aug; 49(8):1362-70. PubMed ID: 18632830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159.
    Wang H; Li D; Liu S; Liu R; Yuan H; Krasnoperov V; Shan H; Conti PS; Gill PS; Li Z
    J Nucl Med; 2015 Jun; 56(6):908-13. PubMed ID: 25908833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
    Nielsen CH; Jensen MM; Kristensen LK; Dahlman A; Fröhlich C; Jacobsen HJ; Poulsen TT; Lantto J; Horak ID; Kragh M; Kjaer A
    Oncotarget; 2015 Nov; 6(35):37486-99. PubMed ID: 26460961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Site-Specific
    Jeppesen TE; Kristensen LK; Nielsen CH; Petersen LC; Kristensen JB; Behrens C; Madsen J; Kjaer A
    Bioconjug Chem; 2018 Jan; 29(1):117-125. PubMed ID: 29206443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.
    Cook BE; Adumeau P; Membreno R; Carnazza KE; Brand C; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
    Bioconjug Chem; 2016 Aug; 27(8):1789-95. PubMed ID: 27356886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
    Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
    Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
    Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
    J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PET imaging of Hsp90 expression in pancreatic cancer using a new
    Wang X; Zhang J; Wu H; Li Y; Conti PS; Chen K
    Amino Acids; 2018 Jul; 50(7):897-907. PubMed ID: 29691700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer:
    Kuroda Y; Oda T; Shimomura O; Louphrasitthiphol P; Mathis BJ; Tateno H; Hatano K
    Cancer Sci; 2023 Aug; 114(8):3364-3373. PubMed ID: 37203465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
    Luo H; England CG; Graves SA; Sun H; Liu G; Nickles RJ; Cai W
    J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and pre-clinical evaluation of a new class of high-affinity
    Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDG.
    Zhao C; Chen Z; Ye X; Zhang Y; Zhan H; Aburano T; Tian M; Zhang H
    Nucl Med Commun; 2009 Dec; 30(12):971-7. PubMed ID: 19696689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
    J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles.
    Girgis MD; Federman N; Rochefort MM; McCabe KE; Wu AM; Nagy JO; Denny C; Tomlinson JS
    J Surg Res; 2013 Nov; 185(1):45-55. PubMed ID: 23827791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma.
    Haylock AK; Spiegelberg D; Mortensen AC; Selvaraju RK; Nilvebrant J; Eriksson O; Tolmachev V; Nestor MV
    Int J Oncol; 2016 Feb; 48(2):461-70. PubMed ID: 26676731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts.
    ter Weele EJ; Terwisscha van Scheltinga AG; Kosterink JG; Pot L; Vedelaar SR; Lamberts LE; Williams SP; Lub-de Hooge MN; de Vries EG
    Oncotarget; 2015 Dec; 6(39):42081-90. PubMed ID: 26536664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colitis ImmunoPET: Defining Target Cell Populations and Optimizing Pharmacokinetics.
    Dearling JL; Daka A; Veiga N; Peer D; Packard AB
    Inflamm Bowel Dis; 2016 Mar; 22(3):529-38. PubMed ID: 26841223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.